Cargando…

433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study

Detalles Bibliográficos
Autores principales: Hernandez, R., Cogen, J., Blanchard, A., Waters, V., Downey, D., Hoffman, L., Hewko, S., Quon, B., Yau, Y., Stephenson, A., Julien, J., Dupont, L., Groves, H., van Koningsbruggen-Rietschel, S., Simmonds, N., Somayaji, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518485/
http://dx.doi.org/10.1016/S1569-1993(21)01857-9
_version_ 1784584234732617728
author Hernandez, R.
Cogen, J.
Blanchard, A.
Waters, V.
Downey, D.
Hoffman, L.
Hewko, S.
Quon, B.
Yau, Y.
Stephenson, A.
Julien, J.
Dupont, L.
Groves, H.
van Koningsbruggen-Rietschel, S.
Simmonds, N.
Somayaji, R.
author_facet Hernandez, R.
Cogen, J.
Blanchard, A.
Waters, V.
Downey, D.
Hoffman, L.
Hewko, S.
Quon, B.
Yau, Y.
Stephenson, A.
Julien, J.
Dupont, L.
Groves, H.
van Koningsbruggen-Rietschel, S.
Simmonds, N.
Somayaji, R.
author_sort Hernandez, R.
collection PubMed
description
format Online
Article
Text
id pubmed-8518485
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Cystic Fibrosis Society.
record_format MEDLINE/PubMed
spelling pubmed-85184852021-10-15 433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study Hernandez, R. Cogen, J. Blanchard, A. Waters, V. Downey, D. Hoffman, L. Hewko, S. Quon, B. Yau, Y. Stephenson, A. Julien, J. Dupont, L. Groves, H. van Koningsbruggen-Rietschel, S. Simmonds, N. Somayaji, R. J Cyst Fibros Posters European Cystic Fibrosis Society. 2021-11 2021-10-15 /pmc/articles/PMC8518485/ http://dx.doi.org/10.1016/S1569-1993(21)01857-9 Text en Copyright © 2021 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Posters
Hernandez, R.
Cogen, J.
Blanchard, A.
Waters, V.
Downey, D.
Hoffman, L.
Hewko, S.
Quon, B.
Yau, Y.
Stephenson, A.
Julien, J.
Dupont, L.
Groves, H.
van Koningsbruggen-Rietschel, S.
Simmonds, N.
Somayaji, R.
433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
title 433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
title_full 433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
title_fullStr 433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
title_full_unstemmed 433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
title_short 433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
title_sort 433: rationale and design of an international multicenter prospective study to evaluate serologic immune responses to sars-cov-2 infection in persons living with cystic fibrosis: the car-cf study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518485/
http://dx.doi.org/10.1016/S1569-1993(21)01857-9
work_keys_str_mv AT hernandezr 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT cogenj 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT blancharda 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT watersv 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT downeyd 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT hoffmanl 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT hewkos 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT quonb 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT yauy 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT stephensona 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT julienj 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT dupontl 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT grovesh 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT vankoningsbruggenrietschels 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT simmondsn 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy
AT somayajir 433rationaleanddesignofaninternationalmulticenterprospectivestudytoevaluateserologicimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosisthecarcfstudy